Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Varování

Publikace nespadá pod Ekonomicko-správní fakultu, ale pod Středoevropský technologický institut. Oficiální stránka publikace je na webu muni.cz.

Autoři	SUTTON Lesley-Ann YOUNG Emma BALIAKAS Panagiotis HADZIDIMITRIOU Anastasia MOYSIADIS Theodoros PLEVOVÁ Karla ROSSI Davide KMÍNKOVÁ Jana STALIKA Evangelia PEDERSEN Lone Bredo MALČÍKOVÁ Jitka AGATHANGELIDIS Andreas DAVIS Zadie MANSOURI Larry SCARFO Lydia BOUDJOGHRA Myriam NAVARRO Alba MUGGEN Alice F. YAN Xiao-Jie NGUYEN-KHAC Florence LARRAYOZ Marta PANAGIOTIDIS Panagiotis CHIORAZZI Nicholas NIEMANN Carsten Utoft BELESSI Chrysoula CAMPO Elias STREFFORD Jonathan C. LANGERAK Anton W. OSCIER David GAIDANO Gianluca POSPÍŠILOVÁ Šárka DAVI Frederic GHIA Paolo STAMATOPOULOS Kostas ROSENQUIST Richard
Rok publikování	2016
Druh	Článek v odborném periodiku
Časopis / Zdroj	Haematologica
Fakulta / Pracoviště MU	Středoevropský technologický institut
Citace
www	http://www.haematologica.org/content/101/8/959.full.pdf+html
Doi	http://dx.doi.org/10.3324/haematol.2016.141812
Obor	Onkologie a hematologie
Klíčová slova	ANTIGEN RECEPTORS; GENOMIC ABERRATIONS; EXPRESSION PROFILES; SF3B1; SELECTION; TP53; CLL; SUBGROUPS; INDICATE; PATTERNS
Popis	We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobulins in the largest cohort (n=565) studied for this purpose. By combining data on recurrent gene mutations (BIRC3, MYD88, NOTCH1, SF3B1 and TP53) and cytogenetic aberrations, we reveal a subset-biased acquisition of gene mutations. More specifically, the frequency of NOTCH1 mutations was found to be enriched in subsets expressing unmutated immunoglobulin genes, i.e. #1, #6, #8 and #59 (22-34%), often in association with trisomy 12, and was significantly different (P<0.001) to the frequency observed in subset #2 (4%, aggressive disease, variable somatic hypermutation status) and subset #4 (1%, indolent disease, mutated immunoglobulin genes). Interestingly, subsets harboring a high frequency of NOTCH1 mutations were found to carry few (if any) SF3B1 mutations. This starkly contrasts with subsets #2 and #3 where, despite their immunogenetic differences, SF3B1 mutations occurred in 45% and 46% of cases, respectively. In addition, mutations within TP53, whilst enriched in subset #1 (16%), were rare in subsets# 2 and #8 (both 2%), despite all being clinically aggressive. All subsets were negative for MYD88 mutations, whereas BIRC3 mutations were infrequent. Collectively, this striking bias and skewed distribution of mutations and cytogenetic aberrations within specific chronic lymphocytic leukemia subsets implies that the mechanisms underlying clinical aggressiveness are not uniform, but rather support the existence of distinct genetic pathways of clonal evolution governed by a particular stereotyped B-cell receptor selecting a certain molecular lesion(s).
Související projekty:	CEITEC - středoevropský technologický institut